News and Announcements
BPS Technology & GetCapital Partner to Offer Finance Products Worth $100M to Merchants
- Published September 09, 2016 11:24AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
8th September 2016, Proactive Investors
BPS Technology Ltd (ASX:BPS) has launched a new business finance product to support and enable its small and medium enterprises (SME) merchant partners.
More than 36,000 SMEs transact in excess of $600 million per annum using BPS’ software and trade exchange technology platforms.
The company has executed a new agreement with Get Capital Pty Ltd, a fintech lender, which will make available a range of finance products to BPS’ 36,000 merchants.
As part of the agreement, GetCapital will provide up to $100 million over the initial year of the agreement to support the partnership.
BPS Financial Ltd, a subsidiary of BPS Technology, will market the tailor-made finance products to its merchant base.
To view the full article, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
